Bayer Cropscience Ltd. - Research Center
506285 BAYERCROP Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 4,734.40 | 4,261.30 | 3,609.40 | 3,167.30 | 2,709.90 |
| Expenses | |||||
| Material consumed | 2,671.20 | 2,449.50 | 1,912.20 | 1,664.00 | 1,602.60 |
| Manufacturing expenses | 14.20 | 12.30 | 14.00 | 11.40 | 6.60 |
| Personnel expenses | 463.10 | 362.20 | 361.60 | 364.20 | 263.90 |
| Selling expenses | 308.00 | 199.10 | 198.20 | 212.50 | 153.50 |
| Adminstrative expenses | 466.80 | 426.50 | 397.00 | 434.10 | 273.90 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 3,923.30 | 3,449.60 | 2,883.00 | 2,686.20 | 2,300.50 |
| Operating profit | 811.10 | 811.70 | 726.40 | 481.10 | 409.40 |
| Other recurring income | 54.60 | 63.80 | 66.00 | 53.10 | 38.80 |
| Adjusted PBDIT | 865.70 | 875.50 | 792.40 | 534.20 | 448.20 |
| Financial expenses | 12.90 | 12.60 | 13.80 | 10.40 | 11.30 |
| Depreciation | 64.50 | 73.50 | 65.30 | 43.80 | 33.10 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 788.30 | 789.40 | 713.30 | 480.00 | 403.80 |
| Tax charges | 201.50 | 301.40 | 108.60 | 142.90 | 103.70 |
| Adjusted PAT | 586.80 | 488.00 | 604.70 | 337.10 | 300.10 |
| Non recurring items | 61.40 | 6.70 | -148.40 | -15.10 | -1.30 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 648.20 | 494.70 | 456.30 | 322.00 | 298.80 |
| Earnigs before appropriation | 2,770.20 | 2,684.50 | 2,346.00 | 2,074.00 | 1,958.20 |
| Equity dividend | 674.20 | 516.90 | 80.00 | 100.60 | 47.90 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 21.60 | 26.90 | 12.20 |
| Retained earnings | 2,096.00 | 2,167.60 | 2,244.40 | 1,946.50 | 1,898.10 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis